Cystic fibrosis-related diabetes testing in Nola
Find health labs to test for Cystic fibrosis-related diabetes in Nola and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Clinica San Michele
Via Montella, 16, 81024 Maddaloni CE, Italia
10.8 km
Diabetes Test by Centro Diagnostica Clinica Di Coppola Diego Srl Di Coppola Diego
Via degli Ortolani, 80, 80144 Napoli NA, Italia
15.6 km
Unverified
A Diabetes Test costs €20.00
See Details
Diabetes Test by Ce.Di.P. Centro Diagnostico Polispecialistico S. Alfonso
Via Filettine, 2, 84016 Pagani SA, Italia
13.7 km
Hemoglobin Test by Analisi Cliniche La Salute (Laboratorio e Diabetologia)
Via Salvatore Gargiulo, 38, 84086 Roccapiemonte SA, Italia
14.3 km
Diabetes Test by Salus Centro Polispecialistico - Napoli
Via Fratelli John e Robert Kennedy, 53, 80017 Melito di Napoli NA, Italia
15.4 km
Hemoglobin Test by Laboratorio Analisi Cliniche Bidello
Via Giuseppe Cosenza, 134, 80053 Castellammare di Stabia NA, Italia
16.2 km
Diabetes Test by Laboratorio di Patologia Clinica Stefano Galdiero srl
Via Gaetano Andreozzi, 19, 81031 Aversa CE, Italia
17 km
Diabetes Test by Igea Piedimonte Srl
SP331, 81016 Piedimonte Matese CE, Italia
30.7 km
Diabetes Test by Centro Diagnostico Poccia
Via Domiziana, 212, 81034 Mondragone CE, Italia
35.8 km
Diabetes Test by FIGEBO - Laboratorio Analisi Cliniche - Centro Polispecialistico
Via Domenico Cimarosa, 63, 03043 Cassino FR, Italia
53.3 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
